Cancer AOP group. National Health and Environmental Effects Research Laboratory, Office of Research and Development, Integrated Systems Toxicology Division, US Environmental Protection Agency, Research Triangle Park, NC. Corresponding author for wiki entry (email@example.com)
This putative adverse outcome pathway (AOP) outlines potential key events leading to a tumor outcome in standard carcinogenicity models. This information is based largely on modes of action described previously in cited literature sources and is intended as a resource template for AOP development and data organization. Presentation in this Wiki does not indicate EPA acceptance of a particular pathway for a given reference agent, only that the information has been proposed in some manner. In addition, this putative AOP relates to the model species indicated and does not directly address issues of human relevance.
Gunin, A. G., Emelianov, V., Tolmachev, A. S., & Tolmacheva, A. (2002). Effect of prolactin and dopaminergic drugs on uterine response to chronic estrogen exposure. J Endocrinol, 172(1), 61-69.
Harleman, J. H., Hargreaves, A., Andersson, H., & Kirk, S. (2012). A review of the incidence and coincidence of uterine and mammary tumors in Wistar and Sprague-Dawley rats based on the RITA database and the role of prolactin. Toxicol Pathol, 40(6), 926-930. doi: 10.1177/0192623312444621
O'Connor, J. C., Plowchalk, D. R., Van Pelt, C. S., Davis, L. G., & Cook, J. C. (2000). Role of prolactin in chloro-S-triazine rat mammary tumorigenesis. Drug Chem Toxicol, 23(4), 575-601. doi: 10.1081/DCT-100101972